Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread.
The most common type of bladder cancer is transitional cell carcinoma, also called urothelial carcinoma.
Research has shown that smoking is a major risk factor for bladder cancer. Bladder cancer is often diagnosed at an early stage.
In a study from the National Cancer Institute, scientists found that aspirin use may improve survival for bladder and breast cancer.
In the study, the team examined the link of aspirin use with the risk of developing new cancers, as well as cancer-associated survival for bladder, breast, esophageal, gastric, pancreatic, and uterine cancers.
Their analysis included 139,896 people (mean age, 66.4 years) participating in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (1993 to 2001).
The researchers found that aspirin use was not linked to the incidence of any studied cancer type.
Aspirin use at least three times/week was linked to increased survival among patients with bladder and breast cancers.
However, there was no survival benefit with esophageal, gastric, pancreatic, or uterine cancer. A similar association between bladder and breast cancer was seen for any aspirin use.
The team says the results add to the accumulating evidence that aspirin may improve survival for some cancers.
If you care about cancer, please read studies about vitamin that is critical to cancer prevention, and Yale study finds the causes of cancer.
For more information about cancer, please see recent studies about weight loss surgery that can cut cancer risk and death, and results showing this vegetable oil could increase the spread of cancer.
The study was published in JAMA Network Open and conducted by Holli A. Loomans-Kropp et al.
Copyright © 2022 Knowridge Science Report. All rights reserved.
